To identify the involvement of ITGB1 in Sema3C-mediated HSCs activation, we found that ITGB1 protein levels were significantly increased in LX-2 cells treated with rhSema3C or supernatants of OE-Sema3C-HCC cells (Fig. 6k). This evidence concerns the gene ITGB1 and hepatocellular carcinoma.